Sionna Therapeutics

Sionna Therapeutics develops small molecules for cystic fibrosis to correct ion channel structure and potentially provide a functional cure.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2025
Stage of Initial Investment
NewCo
Initial Investment Year
2019